|
MPZL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43909999472669E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11690000004216E-06 |
| Normal-vs-Stage2 |
4.904200E-03 |
| Normal-vs-Stage3 |
6.09729999999642E-05 |
| Normal-vs-Stage4 |
1.50834999999017E-05 |
| Stage1-vs-Stage2 |
9.908400E-01 |
| Stage1-vs-Stage3 |
7.097400E-01 |
| Stage1-vs-Stage4 |
4.070300E-02 |
| Stage2-vs-Stage3 |
8.023600E-01 |
| Stage2-vs-Stage4 |
1.021200E-01 |
| Stage3-vs-Stage4 |
1.015360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03220000324811E-08 |
| Normal-vs-AfricanAmerican |
2.446200E-02 |
| Normal-vs-Asian |
3.597800E-02 |
| Caucasian-vs-AfricanAmerican |
2.102800E-01 |
| Caucasian-vs-Asian |
1.434440E-01 |
| AfricanAmerican-vs-Asian |
6.058200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.1584999999067E-08 |
| Normal-vs-Female |
1.50919999997168E-06 |
| Male-vs-Female |
5.919400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.625540E-02 |
| Normal-vs-Age(41-60Yrs) |
7.74530000136053E-08 |
| Normal-vs-Age(61-80Yrs) |
1.96439999999853E-06 |
| Normal-vs-Age(81-100Yrs) |
9.647800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.872810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.361430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.188590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.487400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.201800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.544200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.683990E-02 |
| Normal-vs-Grade 2 |
2.22039999997481E-06 |
| Normal-vs-Grade 3 |
1.91579999999636E-05 |
| Normal-vs-Grade 4 |
1.58700000030265E-07 |
| Grade 1-vs-Grade 2 |
9.907400E-01 |
| Grade 1-vs-Grade 3 |
9.129600E-01 |
| Grade 1-vs-Grade 4 |
1.740410E-02 |
| Grade 2-vs-Grade 3 |
8.686400E-01 |
| Grade 2-vs-Grade 4 |
2.622300E-03 |
| Grade 3-vs-Grade 4 |
4.623000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.920100E-03 |
| Normal-vs-ccB subtype |
8.69310179396621E-11 |
| ccA subtype-vs-ccB subtype |
8.3884999946271E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2299999999632E-06 |
| Normal-vs-N1 |
3.719700E-03 |
| N0-vs-N1 |
1.786210E-02 |
|
|
